BATF3 and B-cell non-Hodgkin lymphoma: These findings are in line with two recent studies which also revealed BATF3 protein expression in 70% of classical HL, in 30% of CD30− DLBCL, in over 60% of CD30+ DLBCL, and in about 90% of primary mediastinal B cell lymphomas [20].